is a prescription drug, not a medicine.
ACTOVIRis an antiviral formulation specifically designed to reduce viral load and eliminate infection-related side effects.
The formulation consists of a glucopyranoside derivative extracted from Korean Panax Ginseng and Epimedium Sagittatum, and a flavonol glycoside. It is used to simultaneously suppress viral proliferation, resulting in DNA polymerase, ribonucleotide reductase, and reverse transcriptase, thereby inducing irreversible damage to the viral structure.
The purpose of this formulation is to simultaneously suppress the side effects of viral infection while reducing the viral load, and to directly inactivate the virus itself at the end of supportive treatment.
The related icaritin derivative exhibits its antiviral properties through enzyme suppression and irreversible damage to the viral structure, while Ginsenoside simultaneously achieves this through both immunostimulatory properties and direct virucidal effects.
ACTOVIRis a food supplement in hard capsule form, containing 9 capsules in a box.
Directions for Use:Take 1 capsule 3 times a day with a glass of water. Recommended use for 3 days.
Ingredients:
Cellulose (Vegetable Microcrystalline Cellulose) (E_460), Horny Goat Weed Extract (Epimedium), Herbal Capsule (Hydroxypropylmethylcellulose), Ginseng Extract (Panax Ginseng), Magnesium salts of fatty acids (E 470b).
Warnings and Precautions:
- Do not exceed the recommended daily portion.
- Dietary supplements cannot replace a normal diet.
- Keep out of reach of children.
- Consult your doctor during pregnancy, breastfeeding, or if you are taking any illness or medication.
- Not recommended for children under 18 years of age or pregnant women.
- In the event of any undesirable side effects, immediately discontinue use and consult your doctor.
- Do not use products whose packaging has been opened or damaged.
If any undesirable effects occur, discontinue use and consult your doctor. Do not use products with missing or damaged packaging.
Side effects:No serious side effects have been reported. Overdose may cause mild hypotension and dizziness. No harmful or limiting effects have been observed regarding the use and operation of vehicles.
Storage Conditions:Keep the product out of reach of children. Store in a dry place away from direct sunlight. Do not store above 25 C or below 5 C.
Herba epimedii (Horny goat weed) has been widely used in traditional Chinese medicine for thousands of years as a kidney tonic and antirheumatic drug. It is a genus of about 60 flowering plants cultivated as a ground cover plant and an aphrodisiac. The bioactive compounds in Herba epimedii are primarily prenylated flavonol glycosides, end products of the flavonoid pathway. Epimedium species are also used as garden plants because of their colorful flowers and leaves. Most bloom in early spring, and the leaves of some species change color in the fall, while other species retain their leaves year-round.
EPIMEDIUM EXTRACT
Icaritin is a flavonoid component of Epimedium isolated from Herba Epimedii. By inhibiting the PPAR-g pathway, it inhibits the adipogenic differentiation of MSCs while enhancing the osteoblastic differentiation of mesenchymal stem cells (MSCs). Icaritin has no effect on MSC proliferation.
. Like other flavonoids, icaritin may exhibit estrogen-like activity.
Epimedium extract icaritin is a herbal supplement claimed to be beneficial in the treatment of sexual problems such as impotence. It is believed to contain a number of active ingredients, including plant compounds and estrogen-like compounds that may have antioxidant activity. The main components of Epimedium brevicornum are icariin, epimedium B, and epimedium C.
It is reported to have anti-inflammatory, anti-proliferative, and anti-tumor effects. It is also reported to have potential effects on the management of erectile dysfunction.
.
Beijing Shenogen Biomedical announced that Icaritin, a Chinese Class I cancer drug, has been granted fast-track review status after the company submitted its new drug approval application to the Beijing Food and Drug Administration. Icaritin is an oral traditional Chinese medicine derived from infertility that targets the a36 estrogen receptor.
ICARITIN USES
1. A metabolite of Icaritin. Icaritin and desmethylicaritin, two metabolites of Icaritin, significantly inhibit the growth of most malignant cells. They also possess significant antiangiogenesis properties, completely inhibiting or eliminating the development of new malignant cells (1).
.
2. The anti-MM activity of icaritin was primarily mediated by inhibiting IL-6 JAK2 STAT3 signaling.
3. The inhibitory activity of icaritin II on the growth of pre-osteoclast RAW264.7 was synergized with icaritin, which may contribute to the efficacy of Herba Epimedii extract in treating bone-related diseases such as osteoporosis.
4. Icaritin may be a novel potent inhibitor by inducing S-phase arrest and apoptosis in human lung carcinoma A549 cells.
5. Icaritin dose-dependently inhibits ENKL cell proliferation and induces apoptosis and cell cycle arrest in the G2 M phase. Additionally, Icaritin upregulates Bax, downregulates Bcl-2 and pBad, and activates caspase-3 and caspase-9.
STEREOSPECIFIC ACTION OF GINSENOSIDE RG3:
.
Ginsenosides, or panaxosides, are a class of natural product steroid glycosides and triterpene saponins. Compounds in this family are found almost exclusively in the plant genus Panax (ginseng). Ginseng has a long history of use in traditional medicine, and the pharmacological effects of ginseng compounds have been investigated.
(20S)-ginsenoside Rg3 is a dammaran substituted with hydroxy groups at the 3beta, 12beta, and 20 pro-S positions of Panax ginseng and Panax japonicus var. The hydroxy group at position 3 has been converted to the corresponding beta-D-glucopyranosyl-beta-D-glucopyranoside, and a double bond has been introduced at positions 24-25. It acts as an apoptosis inducer, an antineoplastic agent, a plant metabolite, and an angiogenesis-modulating agent. It is a ginsenoside, a tetracyclic triterpenoid, and a glycoside. It is derived from (20S)-protopanaxadiol. It is derived from the hydride of a dammaran (5).
Epithelial-mesenchymal transition (EMT) is an important cellular process in which epithelial polarized cells become motile mesenchymal-appearing cells, which consequently promotes the metastatic potential of cancer. Ginseng is a long-known plant belonging to the genus Panax that exhibits a wide range of pharmacological and physiological activities.
Ginsenosides 20-Rg3, the active ingredient of ginseng, have various medicinal effects, such as anti-tumorigenic, anti-angiogenesis, and anti-fatigue activities. In addition, ginsenosides 20(S)-Rg3 and 20(R)-Rg3 are epimers, and this epimerization is produced by steaming. However, the possible role of 20(S)-Rg3 and 20(R)-Rg3 in EMT is unclear. The effects of 20(S)-Rg3 and 20(R)-Rg3 on EMT have not been investigated. Transforming growth factor-beta 1 (TGF-ß1) promotes EMT, migration, invasion, and anoikis resistance of lung adenocarcinoma. To understand the suppressive role of 20(S)-Rg3 and 20(R)-Rg3 in lung cancer migration, invasion, and anoikis resistance (metastasis barrier), the potential use of 20(S)-Rg3 and 20(R)-Rg3 was also investigated. Inhibitors of TGF-ß1-induced EMT in A549 lung cancer cells in vitro. Here, we demonstrated that 20(R)-Rg3, but not 20(S)-Rg3, significantly increased the expression of the epithelial marker E-cadherin and the mesenchymal marker vimentin during the initiation of TGF-ß1-induced EMT. 20(R)-Rg3 also inhibited the TGF-ß1-induced increase in cell migration, invasion, and anoikis resistance of A549 lung cancer cells.
In addition, 20(R)-Rg3 was shown to significantly inhibit TGF-ß1-regulated matrix metalloproteinase-2 and the activation of Smad2 and p38 mitogen-activated protein kinase. Taken together, our findings provide new evidence that 20(R)-Rg3 suppresses lung cancer migration, invasion, and anoikis resistance in vitro by inhibiting TGF-ß1-induced EMT(6).